MyAverix Finance
SHG · Healthcare
Wuhan Thalys Med Tech Co Ltd (603716)
Diagnostics & Research
Wuhan Thalys Med Tech Co Ltd (603716) is listed on SHG in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $4.37B, P/E ratio is 18.00, net margin is -19.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603716
Wuhan Thalys Med Tech Co Ltd (603716) — FAQ
What is Wuhan Thalys Med Tech Co Ltd's market cap?
Wuhan Thalys Med Tech Co Ltd (603716) has a reported market cap of $4.37B (data as of 2026-03-29).
What is 603716's P/E ratio?
The price-to-earnings (P/E) ratio for Wuhan Thalys Med Tech Co Ltd (603716) is 18.00 (data as of 2026-03-29).
Does Wuhan Thalys Med Tech Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Wuhan Thalys Med Tech Co Ltd (603716). Check the MyAverix Finance app for the latest dividend data.
What sector is Wuhan Thalys Med Tech Co Ltd in?
Wuhan Thalys Med Tech Co Ltd (603716) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 603716 listed on?
603716 is listed on SHG.
What is Wuhan Thalys Med Tech Co Ltd's net margin?
Wuhan Thalys Med Tech Co Ltd (603716) reports a net margin of -19.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.